Photo by Vitto Sommella

California Bill To Legalize Possession Of Psychedelics Clears Another Hurdle

A Senate-passed bill to legalize possession of certain psychedelics in California cleared a procedural hurdle — but it faces another critical challenge in the Assembly next week that could decide its fate.

After passing the Senate earlier this year, the legislation from Sen. Scott Wiener (D) has moved through two Assembly committees. It advanced through a second reading on the chamber’s floor last week and was re-referred to the Assembly Appropriations Committee.

Now advocates are focusing on what will happen Aug. 26, when the measure is expected to be considered by the panel during a “suspense hearing,” a process that releases hundreds of bills to the Senate and Assembly floors, where they can go up for debate before the entire chamber of lawmakers.

If it clears the full Assembly then, it would then go back to the Senate for concurrence on recent amendments by Sept. 10 in order to reach the governor’s desk this year. If that doesn’t happen, it could remain floor eligible but wouldn’t be acted upon until January at the earliest.

“This bill is one step in the direction of ending the failed war on drugs.”

California Democratic Sen. Scott Wiener

The worst-case scenario for advocates is if the bill is “held on suspense” in Appropriations next week, which means it would effectively be dead.

Wiener has spent significant energy building support for the reform proposal as it has moved through the full Senate and two Assembly committees, including by holding a recent rally with military veterans, law enforcement and health officials.

SB-519 would remove criminal penalties for possessing numerous psychedelics — including psilocybin mushrooms, DMT, ibogaine, LSD and MDMA — for adults 21 and older.

As a result of changes approved by the latest panel last month, the bill includes limits on personal possession for each substance. That led Decriminalize Nature (DN), a group that’s worked to enact psychedelics reform across the country, to call for the legislation to be tabled while disagreements are worked out.

Carlos Plazola, co-founder of DN, recently told DoubleBlind that the only provision of the legislation that “we’ll die on the hill for is limits.” He said Decriminalize Nature’s “official position is neutral with a request that they park the bill and remove limits for natural plant medicines.”

But Wiener said that he doesn’t want to lose momentum by slowing things down, and said his goal is to “pass this bill this year and to have it signed into law this year.”

Other advocates say they are taking a practical position on the revision, accepting the possession limits in the interest of advancing the reform through a legislature that could otherwise defeat the bill if it contained no such restrictions.

As currently drafted, the prescribed limits for personal possession that would be legalized are: 2 grams of DMT; 15 grams of ibogaine; 0.01 grams of LSD; 4 grams of mescaline; 2 grams of the controlled substance psilocybin or 4 ounces of a plant or fungi containing the controlled substance psilocybin; 2 grams of the controlled substance psilocyn or 4 ounces of a plant or fungi containing the controlled substance of psilocyn, an alkaloid present in most psychedelic mushrooms; or 4 grams of MDMA.

While personal possession limits would be imposed under the revision, facilitators could have aggregate amounts for group use, meaning they could possess the allowable amount for each individual involved in a ceremony. And there would be no limits on personal cultivation.

In a prior Assembly panel, Wiener supported a committee amendment that removed ketamine from the list of psychedelics included in the reform. That’s in addition to a series of technical revisions that have been made to the legislation since it was first introduced.

Wiener has described its prospects going forward as “very challenging,” but he made the case at a recent press event that it is a necessary policy change to advance mental health reform and end criminalization.

Under the measure, the state Department of Public Health would be required to establish a working group “to study and make recommendations regarding possible regulatory systems that California could adopt to promote safe and equitable access to certain substances in permitted legal contexts.” Those recommendations would be due by Jan. 1, 2024.

For psilocybin specifically, the legislation would repeal provisions in California statutes that prohibit the cultivation or transportation of “any spores or mycelium capable of producing mushrooms or other material” that contain the psychoactive ingredient.

The bill originally included record sealing and resentencing provisions for people previously convicted of psychedelics possession, but that language was removed in its last committee stop prior to the Senate floor vote as part of an amendment from the sponsor.

Wiener said the reasoning behind that deletion was that the policy “ended up generating a huge price tag” based on a fiscal analysis, but it could be addressed in separate legislation if the main bill passes.

Speaking at an event hosted by the Psychedelic and Entheogen Academic Council (PEAC) in June, the senator said advancing the legislation would be the first step toward decriminalizing all currently illicit drugs. He later reiterated that point, stating that “this bill is one step in the direction of ending the failed war on drugs.”

While the bill is being described by lawmakers and advocates as simple “decriminalization,” the official legislative analysis of the proposal states that it would “make lawful” the personal possession of these substances.

If the bill does ultimately clear the Assembly, it still remains unclear whether Gov. Gavin Newsom (D) would sign it — though the governor has long been an outspoken critic of the war on drugs.

Mescaline, a psychoactive compound derived from peyote and other cacti, is another controversial psychedelic that was specifically excluded from the bill’s reform provisions in peyote-derived form, but the possession of the compound would be allowed if it comes from other plants such as “the Bolivian Torch Cactus, San Pedro Cactus, or Peruvian Torch Cactus.”

That decision on the peyote exclusion was informed by native groups who have strongly pushed back against decriminalizing the cacti for conservationist reasons and because of its sacred value for their communities.

Meanwhile, California activists recently filed a petition for the 2022 ballot to make the state the first in the nation to legalize psilocybin mushrooms for any use.

The psychedelics effort in the California legislature, which Wiener first previewed back in November, comes as activists are stepping up the push to enact psychedelics reform locally in cities in the state and across the country. The bill notes those efforts in an explanation of the proposal.

This piece is a part of a content sharing arrangement between The News Station and Marijuana Moment.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE, etc.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE, etc.

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!